Connect with us

Technology

Cognex Reports Second Quarter 2026 Results

Published

on

NATICK, Mass., Aug. 5, 2026 /PRNewswire/ — Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today reported financial results for the second quarter ended July 5, 2026.

Second-Quarter Financial and Operating Highlights

Achieved record quarterly revenue of $291 million, driven by broad-based strength across most major end markets; second-quarter revenue increased 17% year over year, or 16% on a constant-currency basis.Operating margin was 29.4%; delivered an Adjusted EBITDA margin of 32.2%, up 1,150 basis points year over year, marking the eighth consecutive quarter of margin expansion.Net income per diluted share was $0.43; generated Adjusted diluted earnings per share of $0.45, up 80% year over year, representing the eighth consecutive quarter of growth.Issued full-year 2026 guidance anticipating strong double-digit revenue growth and significant year-over-year expansion in profitability.Announced the general availability of OneVision™, with hundreds of customers using the platform to accelerate configuration and deployment of AI-powered vision applications.

“Q2 was another strong quarter for Cognex and further evidence that our strategy is driving results,” said Matt Moschner, President and CEO. “We delivered exceptional performance, highlighted by record revenue, strong margin expansion, and significant earnings growth, which we believe reflects both a more favorable demand environment and focused execution across the business. We continue to make meaningful progress against our strategic objectives to extend our leadership in AI-enabled machine vision, deliver the leading customer experience in the industry, and double our customer base.”

Mr. Moschner continued, “We believe that diversification is central to the next chapter of Cognex’s growth. We are focused on broadening our reach across customers, channels, adjacencies and end markets, while prioritizing the automation challenges where we expect our technology can create the most value. We believe this strategy will position Cognex to shape the future of AI-enabled machine vision and deliver more sustainable and profitable growth over time.”

Dennis Fehr, CFO, added, “We believe that our Q2 performance underscores the strength of our profitable growth strategy and the strong leverage in our financial model. We are continuing to transform our operating model to drive higher productivity, support sustainable margin expansion, and strengthen our ability to scale efficiently over time. We believe that this disciplined approach will enable us to support Cognex’s long-term growth objectives while reinforcing our commitment to creating shareholder value.”

Financial Performance Highlights for the Second Quarter
(Dollars in millions, except per share amounts)

Three-months ended

July 05, 2026

June 29, 2025

Y/Y Change

Revenue

$291

$249

+17 %

Operating Income

$86

$43

+100 %

% of Revenue

29.4 %

17.4 %

+1,200 bps

Adjusted EBITDA1

$94

$52

81 %

% of Revenue

32.2 %

20.7 %

+1,150 bps

Net Income per Diluted Share

$0.43

$0.24

+79 %

Adjusted EPS (Diluted)1

$0.45

$0.25

+80 %

1Adjusted EBITDA and Adjusted EPS (Diluted) include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this news release.

Revenue was $291 million, compared with $249 million in the second quarter of 2025, an increase of 17%. Excluding the impact of foreign currency exchange (FX), revenue increased 16% compared to the prior year, driven by broad-based strength across most major end markets.Gross margin was 70.6% compared to 67.4% in the second quarter of 2025. Adjusted gross margin was 71.5% compared to 68.0% in the second quarter of 2025, an increase of 350 basis points. The year-over-year increase was primarily driven by favorable mix and volume. Tariff refunds were not a material contributor to the strong gross margin performance.Operating expenses were $120 million compared to $124 million in the second quarter of 2025, a decrease of 3%. Adjusted operating expenses were $119 million compared to $123 million in the second quarter of 2025, a decrease of 3%. On a constant-currency basis, Adjusted operating expenses decreased 5% year over year, primarily driven by disciplined cost management.Operating income was $86 million compared to $43 million in the second quarter of 2025, an increase of 100%. Operating margin was 29.4% compared to 17.4% in the second quarter of 2025, an increase of 1,200 basis points. Adjusted operating margin was 30.7% compared to 18.7% in the second quarter of 2025, an increase of 1,200 basis points.Adjusted EBITDA was $94 million compared to $52 million in the second quarter of 2025, an increase of 81%. Adjusted EBITDA margin was 32.2% compared to 20.7% in the second quarter of 2025, an increase of 1,150 basis points. The year-over-year expansion was driven by revenue growth and favorable mix.Net income of $73 million compared to $41 million in the second quarter of 2025, an increase of 78%. Adjusted net income of $76 million compared to $43 million in the second quarter of 2025, an increase of 77%.Net income per diluted share was $0.43 compared to $0.24 in the second quarter of 2025, an increase of 79%. Adjusted diluted earnings per share were $0.45 compared to $0.25 in the second quarter of 2025, an increase of 80%.

Balance Sheet and Cash Flow Highlights

As of July 5, 2026, Cognex’s financial position remained strong, with $755 million in cash and investments and no debt.During the second quarter, Cognex generated $69 million of cash from operating activities compared to $43 million in the second quarter of 2025, an increase of 60%.During the second quarter, Cognex generated Free Cash Flow (FCF) of $68 million compared to $40 million in the second quarter of 2025, an increase of 70%. Second quarter FCF conversion rate was 93% of net income and 89% of Adjusted net income. Trailing twelve-month FCF conversion rate was 153% of net income and 114% of Adjusted net income.Cognex paid $14 million in dividends to shareholders in the second quarter.

Dividend

On August 5, 2026, Cognex’s Board of Directors declared a quarterly cash dividend of $0.085 per share. The dividend is payable on September 3, 2026, to all shareholders of record at the close of business on August 20, 2026.

Guidance

Cognex issued third-quarter and full-year 2026 guidance; details are summarized in the tables below.

Table 1: Third-Quarter 2026 Guidance

(Dollars in millions, except per
share amounts)

Q3 2026
Guidance

Q3 2025
Results

Q3 2025
Results
ex CP*

Y/Y 
Change**

Y/Y Change**
ex CP*

Revenue

$300 – $320

$277

$264

+12 %

+17 %

Adj. EBITDA Margin1

32% – 35%

24.9 %

22.1 %

+860 bps

+1,140 bps

Adj. EPS (diluted)1

$0.50 – $0.54

$0.33

$0.28

+58 %

+86 %

Table 2: Full-Year 2026 Guidance

(Dollars in millions, except per
share amounts)

 2026 
Guidance

 2025
Results

2025 Results
ex CP*

Y/Y 
Change**

Y/Y Change**
ex CP*

Revenue

$1,130 – $1,150

$994

$982

+15 %

+16 %

Adj. EBITDA Margin1

29% – 31%

21.5 %

20.7 %

+850 bps

+930 bps

Adj. EPS (diluted)1

$1.64 – $1.68

$1.02

$0.97

+63 %

+71 %

* Excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the “CP”).

** At the midpoint of guidance.

1Cognex has provided the forward-looking non-GAAP measures of adjusted EBITDA margin, and adjusted earnings per share (diluted), but cannot, without unreasonable effort, forecast such items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as reorganization charges, acquisition and integration charges, and amortization of acquisition-related intangible assets, all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of Cognex’s control. Additionally, these items are outside of Cognex’s normal business operations and not used by management to assess Cognex’s operating results. Cognex believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, Cognex believes that the probable significance of such information is low. Information with respect to special items for certain historical periods is included in the section entitled “Reconciliation of Selected Items From GAAP to Non-GAAP”. In Q3 2025 the GAAP operating margin was 20.9% and GAAP earnings per share (diluted) were $0.10, and in full-year 2025, the GAAP operating margin was 16.3% and GAAP earnings per share (diluted) were $0.68.

Analyst Conference Call and Simultaneous Webcast

Cognex will host a conference call on August 6, 2026, at 8:30 a.m. Eastern Daylight Time (EDT). The telephone number is (877) 704-4573 or (201) 389-0911 if outside the United States.A real-time audio broadcast of the conference call or an archived recording, together with a slide presentation, will be accessible on the Events & Presentations page of the Cognex Investor website: www.cognex.com/investor. 

Forward-Looking Statements

Certain statements made in this report, as well as oral statements made by Cognex Corporation (“Cognex”, “we”, “us”, “our”, or the “Company”) from time to time, constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.  Readers can identify these forward-looking statements by our use of the words “expects,” “anticipates,” “estimates,” “potential,” “believes,” “projects,” “intends,” “plans,” “aims,” “will,” “may,” “shall,” “could,” “should,” “opportunity,” “goal,” “objective,” “target,” “milestone” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, financial targets, milestones and related timing expectations, the impacts of our strategic portfolio review, the impact of tariffs, customer demand and order rates and timing of related revenue, future product or revenue mix, research and development activities, sales and marketing activities including our salesforce transformation, new product offerings, innovation and product development activities, customer acceptance of our products, commercial partnerships, capital expenditures, cost management activities including expected annualized operating expense reductions, investments, liquidity, dividends and stock repurchases, strategic and growth plans and opportunities, financial and operating models, acquisitions, and estimated tax benefits and expenses, changes in tax legislation, and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the technological obsolescence of current products, the inability to develop new products, and the inability to achieve growth through expanding and adjacent markets; (2) the impact of competitive pressures; (3) the inability to attract and retain skilled employees and effectively plan for succession, while maintaining our unique corporate culture; (4) the failure to properly manage the distribution of products and services; (5) economic, political, and other risks associated with international sales and operations, including the impact of trade disputes, the imposition of tariffs, the economic climate in China, and the wars and conflicts involving Iran, Ukraine, and Israel and those that may arise in the future in the geographies where we conduct business; (6) the challenges in integrating and achieving expected results from acquired businesses; (7) uncertainty surrounding our future capital needs; (8) the inability to effectively scale our operations and salesforce to support a significantly expanded customer base in an increasing number of geographies; (9) information security breaches and other cybersecurity threats; (10) the failure to comply with laws or regulations relating to data privacy, data protection, artificial intelligence, or other automated technologies; (11) the inability to protect our proprietary technology and intellectual property; (12) the inability to manage direct and indirect disruptions to our supply chain, which could cause delays in obtaining components for our products at reasonable prices; (13) the failure to manufacture and deliver products in a timely manner; (14) the inability to obtain, or the delay in obtaining, components for our products at reasonable prices, including memory chips; (15) the inability to design and manufacture high-quality products; (16) the loss of, or curtailment of purchases by, large customers in the logistics, consumer electronics, or automotive end markets; (17) challenges in accurately forecasting our financial results due to seasonal and cyclical variations in customer purchasing patterns and economic and market volatility; (18) potential impairment charges with respect to our investments or acquired intangible assets; (19) exposure to additional tax liabilities, increases and fluctuations in our effective tax rate, and other tax matters; (20) fluctuations in foreign currency exchange rates and the use of derivative instruments; (21) unfavorable global economic conditions, including, without limitation, increases in interest rates, elevated inflation rates, and recession risks; (22) business disruptions from natural or man-made disasters, public health crises, or other events outside our control; (23) stock price volatility; (24) our involvement in time-consuming and costly litigation or activist shareholder activities; and (25) the failure to effectively transform our operating model, manage our expenses, and achieve expected cost reductions.  The foregoing list should not be construed as exhaustive and we encourage readers to refer to the detailed discussion of risk factors included in Part I – Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”), as updated by Part II – Item 1A of our Quarterly Reports on Form 10-Q as filed with the SEC. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company disclaims any obligation to subsequently revise forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date such statements are made.

COGNEX CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)

July 5, 2026

December 31, 2025

(unaudited)

ASSETS

Current assets:

Cash and cash equivalents

$       302,521

$            262,925

Current investments

101,849

74,037

Accounts receivable, net of allowance for credit losses of $726 and $728 in 2026 and
2025, respectively

216,232

146,713

Unbilled revenue

12,684

16,980

Inventories

142,839

137,889

Prepaid expenses and other current assets

73,755

58,702

Total current assets

849,880

697,246

Non-current investments

350,643

305,339

Property, plant, and equipment, net

81,452

86,015

Operating lease assets

68,543

72,310

Goodwill

381,385

386,279

Intangible assets, net

64,464

81,100

Deferred income taxes

377,830

383,272

Other assets

4,453

4,994

Total assets

$    2,178,650

$          2,016,555

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$        65,060

$              50,203

Accrued expenses

80,586

91,397

Accrued income taxes

9,126

9,141

Deferred revenue and customer deposits

48,978

21,094

Operating lease liabilities

12,281

11,716

Total current liabilities

216,031

183,551

Non-current operating lease liabilities

60,196

64,870

Deferred income taxes

248,888

250,512

Reserve for income taxes

21,963

24,269

Other liabilities

2,017

1,452

Total liabilities

549,095

524,654

Shareholders’ equity:

Preferred stock, $.01 par value – Authorized: 400 shares in 2026 and 2025,
respectively; no shares issued and outstanding

—

—

Common stock, $.002 par value – Authorized: 300,000 shares in 2026 and 2025,
respectively; issued and outstanding: 168,217 and 166,997 shares in 2026 and 2025,
respectively

336

334

Additional paid-in capital

1,294,544

1,138,708

Retained earnings

397,135

406,355

Accumulated other comprehensive loss, net of tax

(62,460)

(53,496)

Total shareholders’ equity

1,629,555

1,491,901

Total liabilities and shareholders’ equity

$    2,178,650

$          2,016,555

 

COGNEX CORPORATION
CONSOLIDATED STATEMENT OF OPERATIONS
(Unaudited)
 (In thousands, except per share amounts)

Three-months Ended

Six-months Ended

July 5, 2026

June 29, 2025

July 5, 2026

June 29, 2025

Revenue

$       291,263

$       249,093

$   559,700

$   465,129

Cost of revenue (1)

85,490

81,217

162,988

152,930

Gross profit

205,773

167,876

396,712

312,199

Percentage of revenue

70.6 %

67.4 %

70.9 %

67.1 %

Research, development, and engineering expenses (1)

32,391

33,102

69,416

67,829

Percentage of revenue

11.1 %

13.3 %

12.4 %

14.6 %

Selling, general, and administrative expenses (1)

87,865

91,341

181,906

174,845

Percentage of revenue

30.2 %

36.7 %

32.5 %

37.6 %

Operating income

85,517

43,433

145,390

69,525

Percentage of revenue

29.4 %

17.4 %

26.0 %

14.9 %

Foreign currency gain (loss)

(862)

(1,503)

(2,207)

(3,956)

Investment income

5,091

4,040

9,927

8,030

Other income (expense)

(446)

2,092

(2,053)

2,261

Income before income tax expense

89,300

48,062

151,057

75,860

Income tax expense

16,544

7,551

26,597

11,746

Net income

$         72,756

$         40,511

$   124,460

$     64,114

Percentage of revenue

25.0 %

16.3 %

22.2 %

13.8 %

Net income per weighted-average common and common-
equivalent share:

Basic

$            0.43

$            0.24

$       0.75

$       0.38

Diluted

$            0.43

$            0.24

$       0.74

$       0.38

Weighted-average common and common-equivalent
shares outstanding:

Basic

167,346

167,886

166,921

168,568

Diluted

169,989

168,563

169,166

169,553

Cash dividends per common share

$          0.085

$          0.080

$      0.170

$      0.160

(1) Amounts include stock-based compensation expense, as follows:

Cost of revenue

$            592

$            537

$      1,517

$      1,205

Research, development, and engineering

3,388

3,443

8,482

8,139

Selling, general, and administrative

7,232

8,314

13,146

12,889

Total stock-based compensation expense

$         11,212

$         12,294

$    23,145

$     22,233

Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures, including adjusted gross profit and margin, adjusted operating expense, adjusted operating income and margin, adjusted EBITDA and margin, adjusted net income, adjusted earnings per share of common stock, diluted, adjusted effective tax rate, and free cash flow and free cash flow conversion rate. Cognex defines its non-GAAP metrics as follows:

Adjusted gross profit and margin: Gross margin adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.Adjusted operating expense: Operating expense adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.Adjusted operating income and margin: Operating income adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.Adjusted EBITDA and margin: Operating income adjusted for amortization of acquisition-related intangible assets and depreciation, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.Adjusted net income: Net income adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs, discrete tax items, tax impact on reconciling items and one-time discrete events (such as loss on sale of business).Adjusted earnings per share of common stock, diluted: Adjusted net income divided by diluted weighted average common and common-equivalent shares.Adjusted effective tax rate: Effective tax rate adjusted for discrete tax items and the net impact of the other non-GAAP adjustments.Free cash flow: Cash provided by operating activities less cash for capital expenditures.Free cash flow conversion rate: Free cash flow divided by net income or adjusted net income, as applicable.

Cognex may disclose results on a constant-currency basis as one measure to evaluate its performance and compare results between periods as if the exchange rates had remained constant period-over-period.

Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare results over multiple periods using the same methodology that management employs in its budgeting process, in its review of operating results, and for forecasting and planning for future periods. Cognex’s definitions may differ from the definitions used by other companies and therefore comparability may be limited. In addition, other companies may not publish these or similar metrics. Furthermore, these measures have certain limitations in that they do not include the impact of certain non-recurring expenses that are reflected in our consolidated statement of operations that are necessary to run our business. Thus, our non-GAAP financial measures should be considered in addition to, not as substitutes for, or in isolation from, measures prepared in accordance with GAAP.

Please see the section “Reconciliation of Selected Items from GAAP to Non-GAAP” below for more detailed information regarding non-GAAP financial measures herein, including the items reflected in our adjusted financial metrics and a description of these adjustments.

COGNEX CORPORATION
RECONCILIATION OF SELECTED ITEMS FROM GAAP TO NON-GAAP
Dollars in thousands, except per share amounts 
(Unaudited)

Three-months Ended

Six-months Ended

July 5, 2026

June 29, 2025

July 5, 2026

June 29, 2025

Gross profit (GAAP)

$    205,773

$    167,876

$    396,712

$    312,199

Acquisition and integration costs

218

211

434

453

Amortization of acquisition-related intangible assets

1,323

1,382

2,660

2,720

Reorganization charges

921

—

1,295

86

Adjusted gross profit

$    208,235

$    169,469

$    401,101

$    315,458

GAAP gross margin

70.6 %

67.4 %

70.9 %

67.1 %

Adjusted gross margin

71.5 %

68.0 %

71.7 %

67.8 %

Operating expense (GAAP)

$    120,256

$    124,443

$    251,322

$    242,674

Acquisition and integration costs

(15)

(259)

(30)

(797)

Amortization of acquisition-related intangible assets

(972)

(1,296)

(2,167)

(2,586)

Reorganization charges

(335)

—

(5,090)

(1,622)

Adjusted operating expense

$    118,934

$    122,888

$    244,035

$    237,669

Operating income (GAAP)

$     85,517

$     43,433

$    145,390

$      69,525

Acquisition and integration costs

233

470

464

1,250

Amortization of acquisition-related intangible assets

2,295

2,678

4,827

5,306

Reorganization charges

1,256

—

6,385

1,708

Adjusted operating income

$      89,301

$     46,581

$    157,066

$      77,789

GAAP operating margin

29.4 %

17.4 %

26.0 %

14.9 %

Adjusted operating margin

30.7 %

18.7 %

28.1 %

16.7 %

Depreciation (adjusted for amounts included in Acquisition and
integration costs)

4,358

5,095

8,830

10,178

Adjusted EBITDA

$     93,659

$     51,676

$    165,896

$      87,967

Adjusted EBITDA margin

32.2 %

20.7 %

29.6 %

18.9 %

Net income (GAAP)

$     72,756

$     40,511

$    124,460

$      64,114

Acquisition and integration costs

233

470

464

1,250

Amortization of acquisition-related intangible assets

2,295

2,678

4,827

5,306

Reorganization charges

1,256

—

6,385

1,708

Loss on sale of business

—

—

1,539

—

Discrete tax (benefit) expense

450

(211)

(729)

(518)

Tax impact of reconciling items

(1,102)

(891)

(3,740)

(2,256)

Adjusted net income

$      75,888

$     42,557

$    133,206

$      69,604

Earnings per share of common stock, diluted (GAAP)

$        0.43

$        0.24

$        0.74

$        0.38

Acquisition and integration costs

0.00

0.00

0.00

0.01

Amortization of acquisition-related intangible assets

0.01

0.02

0.03

0.03

Reorganization charges

0.01

—

0.04

0.01

Loss on sale of business

—

—

0.01

—

Discrete tax (benefit) expense

0.00

0.00

0.00

0.00

Tax impact of reconciling items

(0.01)

(0.01)

(0.02)

(0.01)

Adjusted earnings per share of common stock, diluted

$        0.45

$        0.25

$        0.80

$        0.41

Effective tax rate (GAAP)

18.5 %

15.7 %

17.6 %

15.5 %

Discrete tax benefit (expense)

(0.5) %

0.4 %

0.5 %

0.7 %

Net impact of other reconciling items

0.4 %

0.7 %

0.8 %

1.1 %

Adjusted effective tax rate

18.5 %

16.9 %

18.9 %

17.3 %

Cash provided by operating activities (GAAP)

$     69,153

$     42,625

$    114,246

$      83,127

Capital expenditures

(1,532)

(2,194)

(4,289)

(4,695)

Free cash flow

$      67,621

$     40,431

$    109,957

$      78,432

Description of adjustments:

In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Adjustments incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below:

Depreciation:

The company incurs expense related to its normal use of property, plant and equipment.

Acquisition and integration costs:

The Company has incurred charges related to the purchase and integration of acquired businesses. During the periods presented, these costs were primarily related to the ongoing integration of Moritex Corporation, which the company acquired in the fourth quarter of 2023.

Amortization of acquisition-related intangible assets:

The Company excludes the amortization of acquired intangible assets from non-GAAP expense and income measures. These items are inconsistent in amount and frequency and are significantly impacted by the timing and size of acquisitions, and include the amortization of customer relationships, completed technologies, and trademarks that originated from prior acquisitions. The largest driver of intangible asset amortization was the acquisition of Moritex Corporation.

Reorganization charges:

The Company has incurred charges related to the reorganization of its employees. During the three-month period ended July 5, 2026, these costs consisted primarily of severance and consulting fees.

Loss on sale of business:

The Company has recognized a pre-tax loss related to the divestiture of its Japan-focused trading business, which includes direct costs associated with the divestiture incurred during the six-month period ended July 5, 2026.

Discrete tax (benefit) expense and tax impact of reconciling items:

Items unrelated to current period ordinary income or (loss) that generally relate to changes in tax laws, adjustments to prior period’s actual liability determined upon filing tax returns, adjustments to previously recorded reserves for uncertain tax positions, establishments and adjustments of valuation allowances, stock based compensation, and adjustments to deferred tax positions.We estimate the tax effect of items identified in the reconciliation by applying the statutory tax rate to the pre-tax amount.

About Cognex Corporation

For over 40 years, Cognex has been making advanced machine vision easy, paving the way for manufacturing and distribution companies to become faster, smarter, and more efficient through automation. Innovative technology in our vision sensors and systems solves critical manufacturing and distribution challenges, providing unparalleled performance for industries from automotive to consumer electronics to packaged goods.

Cognex makes these tools more capable and easier to deploy thanks to a longstanding focus on AI, helping factories and warehouses improve quality and maximize efficiency without needing highly technical expertise. We are headquartered near Boston, USA, with locations in over 30 countries and more than 30,000 customers worldwide. Learn more at cognex.com.

Investor Relations Contact:
Greer Aviv – Head of Investor Relations
Cognex Corporation
Greer.Aviv@cognex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cognex-reports-second-quarter-2026-results-302844140.html

SOURCE Cognex Corporation

Continue Reading

Technology

Silicon Labs Reports Third Quarter 2026 Results

Published

on

By

Wireless IoT leader delivers $251 million in revenue and strong earnings growth

AUSTIN, Texas, Nov. 10, 2026 /PRNewswire/ — Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for the third quarter, which ended October 3, 2026.

“We delivered strong third-quarter results, with revenue up 10% sequentially, underpinned by broad-based growth across many end applications and another record quarter for medical revenue as known customer ramps continued,” said Matt Johnson, President and Chief Executive Officer. “Earnings significantly outpaced revenue growth, a result of strong operational execution by the team. Looking ahead, our current backlog and design-win ramps position us for continued revenue growth and meaningful earnings expansion.”

Third Quarter Financial Highlights 

Revenue was $251 million, up 22% year-over-yearIndustrial & Commercial revenue was $141 million, up 20% year-over-yearHome & Life revenue was $110 million, up 24% year-over-yearBookings imply a healthy demand environment, while distributor inventory declined further to a multi-year low and end customer inventory was near record lows during the quarterMedical revenue reached a new quarterly record, increasing 48% sequentially and more than 300% year-over-yearGAAP diluted earnings per share was $0.26, compared with a loss of $0.30 in the year-ago quarterNon-GAAP diluted earnings per share was $1.05, up 228% over the comparable period last year

Results on a GAAP basis:

GAAP gross margin was 60.8%GAAP operating expenses were $145 millionGAAP operating income was $8 millionGAAP diluted earnings per share was $0.26

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, merger-related costs, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

Non-GAAP gross margin was 61.0%Non-GAAP operating expenses were $113 millionNon-GAAP operating income was $40 millionNon-GAAP diluted earnings per share was $1.05

Due to the announced pending acquisition of Silicon Labs by Texas Instruments, Silicon Labs has suspended providing forward-looking guidance.

About Silicon Labs 

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world’s most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding Silicon Labs’ current expectations, which are based on its current views and assumptions. The words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”, “project”, “will”, and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements, although the absence of such words does not necessarily mean a statement is not forward looking. These forward-looking statements include, but are not necessarily limited to, Silicon Labs’ expectations regarding its near- and long-term strength and continued revenue growth and earnings expansion and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations that are expressed or implied herein. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: our ability to complete the merger with Texas Instruments within the time frame expected, or at all, as well as potential disruptions in our business and restrictions on our activities during the pendency of the merger; fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the impact of the current global memory chip shortage; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders. 

For more information: Silicon Labs Investor Relations, investor.relations@silabs.com

Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations 

(In thousands, except per share data) 

(Unaudited)

Three Months Ended

Nine Months Ended

October 3,
2026

October 4,
2025

October 3,
2026

October 4,
2025

Revenues

$       250,892

$       205,999

$       692,581

$       576,558

Cost of revenues

98,314

86,980

272,331

251,653

Gross profit

152,578

119,019

420,250

324,905

Operating expenses:

Research and development

93,174

87,685

276,784

263,725

Selling, general and administrative

51,453

43,676

163,263

128,469

Operating expenses

144,627

131,361

440,047

392,194

Operating income (loss)

7,951

(12,342)

(19,797)

(67,289)

Other income (expense):

Interest income and other, net

3,185

3,046

9,300

10,672

Interest expense

(226)

(226)

(709)

(761)

Income (loss) before income taxes

10,910

(9,522)

(11,206)

(57,378)

Provision for income taxes

2,059

414

6,432

4,845

Net income (loss)

$          8,851

$         (9,936)

$       (17,638)

$       (62,223)

Earnings (loss) per share:

Basic

$           0.27

$          (0.30)

$          (0.53)

$          (1.91)

Diluted

$           0.26

$          (0.30)

$          (0.53)

$          (1.91)

Weighted-average common shares outstanding:

Basic

33,376

32,835

33,182

32,656

Diluted

33,752

32,835

33,182

32,656

Non-GAAP Financial Measurements

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

Three Months Ended

October 3, 2026

Non-GAAP Income Statement Items

GAAP

Measure

GAAP

Percent of

Revenue

Stock

Compensation

Expense

Intangible
Asset

Amortization

Merger-
Related Costs

Non-
GAAP

Measure

Non-GAAP

Percent of

Revenue

Revenues

$ 250,892

Gross profit

152,578

60.8 %

$        459

$          —

$         —

$153,037

61.0 %

Research and development

93,174

37.1 %

11,996

2,295

3,623

75,260

30.0 %

Selling, general and administrative

51,453

20.5 %

10,594

—

3,281

37,578

15.0 %

Operating expenses

144,627

57.6 %

22,590

2,295

6,904

112,838

45.0 %

Operating income

7,951

3.2 %

23,049

2,295

6,904

40,199

16.0 %

 

Three Months Ended

October 3, 2026

Non-GAAP Earnings Per Share

GAAP

Measure

Stock

Compensation

Expense*

Intangible

Asset

Amortization*

Merger-
Related Costs*

Income

Tax

Adjustments**

Non-

GAAP

Measure

Net income (loss)

$    8,851

$     23,049

$       2,295

$       6,904

$      (5,710)

$     35,389

Diluted shares outstanding

33,752

33,752

Diluted earnings per share

$     0.26

$       1.05

*   Represents pre-tax amounts

**  Represents the application of an 18% non-GAAP tax rate

 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets 

(In thousands, except per share data) 

(Unaudited)

October 3,
2026

January 3,
2026

Assets

Current assets:

Cash and cash equivalents

$       423,013

$       364,222

Short-term investments

16,828

79,400

Accounts receivable, net

79,966

64,513

Inventories

133,391

95,566

Prepaid expenses and other current assets

71,421

70,316

Total current assets

724,619

674,017

Property and equipment, net

131,687

128,643

Goodwill

376,389

376,389

Other intangible assets, net

16,246

23,130

Other assets, net

87,213

67,138

Total assets

$     1,336,154

$     1,269,317

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$        68,860

$        50,717

Deferred revenue and returns liability

9,804

5,359

Other current liabilities

78,841

87,711

Total current liabilities

157,505

143,787

Other non-current liabilities

53,267

31,112

Total liabilities

210,772

174,899

Commitments and contingencies

Stockholders’ equity:

Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued

—

—

Common stock – $0.0001 par value; 250,000 shares authorized; 33,384 and 32,955
     shares issued and outstanding at October 3, 2026 and January 3, 2026, respectively

3

3

Additional paid-in capital

206,203

157,402

Retained earnings

919,176

936,814

Accumulated other comprehensive income

—

199

Total stockholders’ equity

1,125,382

1,094,418

Total liabilities and stockholders’ equity

$     1,336,154

$     1,269,317

 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows 

(In thousands) 

(Unaudited)

Nine Months Ended

October 3,
2026

October 4,
2025

Operating Activities

Net loss

$       (17,638)

$       (62,223)

Adjustments to reconcile net loss to net cash provided by operating activities:

Depreciation of property and equipment

18,154

18,769

Amortization of other intangible assets

6,884

11,074

Stock-based compensation expense

69,754

59,645

Deferred income taxes

2,164

2,026

Changes in operating assets and liabilities:

Accounts receivable

(15,453)

(12,829)

Inventories

(37,828)

23,316

Prepaid expenses and other assets

(35,213)

9,080

Accounts payable

18,373

11,141

Other current liabilities and income taxes

3,271

29,901

Deferred revenue and returns liability

4,445

5,374

Other non-current liabilities

20,285

(7,916)

Net cash provided by operating activities

37,198

87,358

Investing Activities

Purchases of marketable securities

—

(34,790)

Sales of marketable securities

—

15,332

Maturities of marketable securities

62,309

22,598

Purchases of property and equipment

(28,472)

(19,942)

Proceeds from capital-related government incentives

8,705

—

Purchase of other investment

—

(4,000)

Net cash provided by (used in) investing activities

42,542

(20,802)

Financing Activities

Payment of taxes withheld for vested stock awards

(28,710)

(14,907)

Proceeds from the issuance of common stock

7,761

8,147

Net cash used in financing activities

(20,949)

(6,760)

Increase in cash and cash equivalents

58,791

59,796

Cash and cash equivalents at beginning of period

364,222

281,607

Cash and cash equivalents at end of period

$       423,013

$       341,403

View original content to download multimedia:https://www.prnewswire.com/news-releases/silicon-labs-reports-third-quarter-2026-results-302935539.html

SOURCE Silicon Labs

Continue Reading

Technology

QuickLogic Reports Fiscal Third Quarter 2026 Financial Results

Published

on

By

SAN JOSE, Calif., Nov. 10, 2026 /PRNewswire/ — QuickLogic® Corporation (NASDAQ: QUIK) (“QuickLogic” or the “Company”), a developer of embedded FPGA (“eFPGA”) Hard IP, Strategic Radiation Hardened and Antifuse FPGAs, and ruggedized programmable logic solutions, today announced its financial results for the fiscal third quarter ended September 27, 2026.

Recent Highlights

Secured a six-figure eFPGA Hard IP design win for an automotive industrial SoC targeting battery management, precision motor control, and robotic applications on a 16nm process technologyExpanded our eFPGA IP portfolio with a new 12LP core featuring enhanced DSP capabilities, scalability beyond 250,000 LUTs, and optional configuration-bit health monitoring for improved reliability in mission-critical applicationsAppointed James Sullivan as Senior Vice President of Finance and Chief Financial Officer

“Our recent automotive and industrial design win is a strong validation of our eFPGA technology,” said Brian Faith, CEO of QuickLogic. “Combined with our latest eFPGA Hard IP advancements and continued progress on the U.S. strategic radiation-hardened FPGA program, we are building momentum across key areas of our business and anticipate a strong finish to the year.”

Fiscal Third Quarter 2026 Financial Results

Total revenue from continuing operations for the third quarter of fiscal 2026 was $5.1 million, an increase of 153.2% compared with the third quarter of 2025 and a decrease of 6.3% compared with the second quarter of 2026.

New product revenue from continuing operations was approximately $4.0 million for the third quarter of 2026, an increase of $3.1 million, or 324.4%, compared with the third quarter of 2025 and a decrease of $0.6 million, or 13.2%, compared with the second quarter of 2026.

Mature product revenue from continuing operations was $1.1 million for the third quarter of 2026, compared with $1.1 million in the third quarter of 2025 and $0.8 million in the second quarter of 2026.

Third quarter 2026 GAAP gross margin from continuing operations was 37.4%, compared with (23.3%) in the third quarter of 2025 and 43.9% in the second quarter of 2026.

Third quarter 2026 non-GAAP gross margin from continuing operations was 41.0%, compared with (11.9%) in the third quarter of 2025 and 46.8% in the second quarter of 2026.

Third quarter 2026 GAAP operating expenses from continuing operations were $4.0 million, compared with $3.5 million in the third quarter of 2025 and $4.1 million in the second quarter of 2026.

Third quarter 2026 non-GAAP operating expenses from continuing operations were $3.3 million, compared with $2.9 million in the third quarter of 2025 and $3.5 million in the second quarter of 2026.

Third quarter 2026 GAAP net loss was ($2.2 million), or ($0.12) per share, compared with a net loss of ($4.0 million), or ($0.24) per share, in the third quarter of 2025, and a net loss of ($0.9 million), or ($0.05) per share, in the second quarter of 2026.

Third quarter 2026 non-GAAP net loss was ($1.3 million), or ($0.07) per share, compared with a net loss of ($3.2 million), or ($0.19) per share, in the third quarter of 2025, and a net loss of ($1.1 million), or ($0.06) per share, in the second quarter of 2026.

Conference Call

QuickLogic will hold a conference call at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time today, November 10, 2026, to discuss its current financial results. The conference call will be webcast on QuickLogic’s IR Site Events Page at https://ir.quicklogic.com/ir-calendar. To join the live conference, you may dial (877) 407-0792 and international participants should dial (201) 689-8263 by 2:20 p.m. Pacific Time. A recording of the call will be available approximately one hour after completion. To access the recording, please call (844) 512-2921 and reference the passcode 13763456.

The call recording, which can be accessed by phone, will be available through November 17, 2026, and the webcast will be available for 12 months on the Company’s website.

About QuickLogic

QuickLogic is a fabless semiconductor company specializing in eFPGA Hard IP, Strategic Radiation Hardened and Antifuse FPGAs, and ruggedized programmable logic solutions. QuickLogic’s unique approach combines cutting-edge technology with open-source tools to deliver highly customizable low-power solutions for aerospace and defense, industrial, computing, and consumer markets. For more information, visit www.quicklogic.com.

QuickLogic uses its website (www.quicklogic.com), its blog (https://www.quicklogic.com/blog/), and LinkedIn page (https://www.linkedin.com/company/13512/) as channels of distribution of information about its products, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and QuickLogic may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor the Company’s website and its social media accounts, in addition to following the Company’s press releases, SEC filings, public conference calls, and webcasts.

Non-GAAP Financial Measures

QuickLogic reports financial information in accordance with United States Generally Accepted Accounting Principles (“GAAP”), but believes that non-GAAP financial measures are helpful in evaluating its operating results and comparing its performance to comparable companies. Accordingly, the Company excludes certain charges related to stock-based compensation, impairment charges, and restructuring costs, as well as significant non-recurring gains, in calculating non-GAAP (i) operating expenses, (ii) income (loss) from operations, (iii) net income (loss), (iv) net income (loss) per share, and (v) cost of revenue and gross margin percentage. The Company provides this non-GAAP information to enable investors to evaluate its operating results in a manner consistent with how the Company analyzes its operating results and to provide consistency and comparability with similar companies in the Company’s industry.

Management uses the non-GAAP measures, which exclude gains, losses, and other charges that are considered by management to be outside of the Company’s core operating results, internally to evaluate its operating performance against results in prior periods and its operating plans and forecasts. In addition, the non-GAAP measures are used to plan for the Company’s future periods and serve as a basis for the allocation of the Company’s resources, management of operations and the measurement of profit-dependent cash flows, and equity compensation paid to employees and executive officers.

Investors should note, however, that the non-GAAP financial measures used by QuickLogic may not be the same non-GAAP financial measures and may not be calculated in the same manner as that of other companies. QuickLogic does not, nor does it suggest that investors should, consider such non-GAAP financial measures alone or as a substitute for financial information prepared in accordance with GAAP. A reconciliation of GAAP financial measures to non-GAAP financial measures is included in the financial statements portion of this press release. Investors are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP financial measures with their most directly comparable GAAP financial measures.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding the Company’s future profitability, revenue growth, and cash flows, expectations regarding its future business and statements regarding the timing, milestones, and payments related to its government contracts, statements regarding expected contracts and the expected magnitude of such contracts, and statements regarding expected adoption rates and/or orders by customers. Actual results may differ due to a variety of factors including: delays in the market acceptance of the Company’s new products; the ability to convert design opportunities into customer revenue; the ability to replace revenue from end-of-life products; the level and timing of customer design activity; the market acceptance of the Company’s customers’ products; the risk that orders may not result in future revenue; ability to introduce and produce new products based on advanced wafer technology on a timely basis; ability to adequately market the low power, competitive pricing, and short time-to-market of the Company’s new products; intense competition; ability to hire and retain qualified personnel; changes in product demand or supply; general economic conditions; political events, international trade disputes, natural disasters, and other business interruptions that could disrupt supply or delivery of, or demand for, the Company’s products; and changes in tax rates and exposure to additional tax liabilities. These and other potential factors and uncertainties that could cause actual results to differ materially from the results contemplated or implied are described in more detail in the Company’s public reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including the risks discussed in the “Risk Factors” section in the Company’s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, as well as disclosed in the Company’s prior press releases, which are available on the Company’s Investor Relations website at http://ir.quicklogic.com/ and on the SEC website at www.sec.gov/. In addition, please note that the date of this press release is November 10, 2026, and any forward-looking statements contained herein are based on management’s current expectations and assumptions that the Company believes to be reasonable as of this date. QuickLogic is not obliged to update these statements even as new information becomes available or other events occur in the future.

QuickLogic and logo are registered trademarks of QuickLogic. All other trademarks are the property of their respective holders and should be treated as such.

CODE: QUIK-E 

 –Tables Follow –

QUICKLOGIC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(Unaudited) 

Three Months Ended

Nine Months Ended

September
27, 2026

September
28, 2025

June 28,
2026

September
27, 2026

September
28, 2025

Revenue

$

5,138

$

2,029

$

5,482

$

15,671

$

10,041

Cost of revenue

3,217

2,501

3,075

9,501

7,682

Gross profit (loss)

1,921

(472)

2,407

6,170

2,359

Operating expenses:

Research and development

1,491

1,398

1,556

4,559

3,859

Selling, general and administrative

2,512

2,057

2,552

7,501

6,555

Impairment charges

—

—

—

—

300

Restructuring costs

34

—

16

61

75

Total operating expenses

4,037

3,455

4,124

12,121

10,789

Operating income (loss)

(2,116)

(3,927)

(1,717)

(5,951)

(8,430)

Interest expense

(39)

(87)

(71)

(164)

(292)

Interest income and other income (expense), net

(16)

9

(41)

(90)

(28)

Gain on extinguishment of vendor payable

—

—

950

950

—

Income (loss) from continuing operations before
income taxes

(2,171)

(4,005)

(879)

(5,255)

(8,750)

(Benefit from) provision for income taxes

8

(1)

3

8

5

Net income (loss) from continuing operations

(2,179)

(4,004)

(882)

(5,263)

(8,755)

Net income (loss) from discontinued operations, net
     of taxes and inclusive of $87 in restructuring
     costs for the nine months ended September 28,
     2025

(4)

(3)

(5)

(13)

(113)

Net income (loss)

$

(2,183)

$

(4,007)

$

(887)

$

(5,276)

$

(8,868)

Net income (loss) from continuing operations per
share:

Basic

$

(0.12)

$

(0.24)

$

(0.05)

$

(0.29)

$

(0.55)

Diluted

$

(0.12)

$

(0.24)

$

(0.05)

$

(0.29)

$

(0.55)

Net income (loss) per share:

Basic

$

(0.12)

$

(0.24)

$

(0.05)

$

(0.29)

$

(0.56)

Diluted

$

(0.12)

$

(0.24)

$

(0.05)

$

(0.29)

$

(0.56)

Weighted average shares outstanding:

Basic

18,419

16,516

18,110

17,999

15,957

Diluted

18,419

16,516

18,110

17,999

15,957

Note: Income taxes related to discontinued operations were immaterial in nature for the periods presented and as such, only net income (loss) from discontinued operations was reported herein.

 

QUICKLOGIC CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(Unaudited)

September 27,
2026

December 28,
2025

ASSETS

Current assets:

Cash and cash equivalents

$

19,199

$

18,840

Accounts receivable, net

1,030

2,809

Contract assets

335

217

Inventories

938

956

Prepaid expenses and other

2,308

1,399

Assets of business held for disposal, net

—

2

Total current assets

23,810

24,223

Property and equipment, net

16,197

18,233

Capitalized internal-use software, net

1,429

1,117

Right of use assets, net

226

464

Intangible assets, net

310

339

Inventories

—

187

Other assets

266

241

TOTAL ASSETS

$

42,238

$

44,804

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Revolving line of credit

$

5,000

$

15,000

Trade payables

2,235

2,251

Accrued liabilities

1,732

1,779

Deferred revenue

786

64

Notes payable, current

1,466

1,870

Lease liabilities, current

218

321

Total current liabilities

11,437

21,285

Long-term liabilities:

Lease liabilities

—

126

Notes payable

823

926

Total liabilities

12,260

22,337

Stockholders’ equity:

Preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and
     outstanding

—

—

Common stock, $0.001 par value; 200,000 authorized; 18,754 and 17,290 shares issued
     and outstanding as of September 27, 2026 and December 28, 2025, respectively

19

17

Additional paid-in capital

359,447

346,662

Accumulated deficit

(329,488)

(324,212)

Total stockholders’ equity

29,978

22,467

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$

42,238

$

44,804

 

QUICKLOGIC CORPORATION

SUPPLEMENTAL RECONCILIATIONS OF GAAP AND NON-GAAP FINANCIAL MEASURES

(in thousands, except per share amounts and percentages)

(Unaudited)

Three Months Ended

Nine Months Ended

September
27, 2026

September
28, 2025

June 28,
2026

September
27, 2026

September
28, 2025

GAAP operating income (loss)

$

(2,116)

$

(3,927)

$

(1,717)

$

(5,951)

$

(8,430)

Adjustment for stock-based compensation within:

Cost of revenue

184

231

158

498

578

Research and development

134

96

139

481

443

Selling, general and administrative

572

501

457

1,523

1,586

Adjustment for impairment charges

—

—

—

—

300

Adjustment for restructuring costs

34

—

16

61

75

Non-GAAP operating income (loss)

$

(1,192)

$

(3,099)

$

(947)

$

(3,388)

$

(5,448)

GAAP net income (loss) from continuing
operations

$

(2,179)

$

(4,004)

$

(882)

$

(5,263)

$

(8,755)

Adjustment for stock-based compensation within:

Cost of revenue

184

231

158

498

578

Research and development

134

96

139

481

443

Selling, general and administrative

572

501

457

1,523

1,586

Adjustment for impairment charges

—

—

—

—

300

Adjustment for restructuring costs

34

—

16

61

75

Adjustment for significant non-recurring gain

—

—

(950)

(950)

—

Non-GAAP net income (loss) from continuing
operations

$

(1,255)

$

(3,176)

$

(1,062)

$

(3,650)

$

(5,773)

GAAP net income (loss) from discontinued
operations

$

(4)

$

(3)

$

(5)

$

(13)

$

(113)

Adjustment for stock-based compensation within:

Research and development

—

—

—

—

(32)

Adjustment for restructuring costs

—

—

—

—

87

Non-GAAP net income (loss) from discontinued
operations

$

(4)

$

(3)

$

(5)

$

(13)

$

(58)

Non-GAAP net income (loss)

$

(1,259)

$

(3,179)

$

(1,067)

$

(3,663)

$

(5,831)

GAAP net income (loss) from continuing
operations per share, basic

$

(0.12)

$

(0.24)

$

(0.05)

$

(0.29)

$

(0.55)

Adjustment for stock-based compensation

0.05

0.05

0.04

0.14

0.16

Adjustment for impairment charges

—

—

—

—

0.02

Adjustment for restructuring costs

—

—

—

—

0.01

Adjustment for significant non-recurring gain

—

—

(0.05)

(0.05)

—

Non-GAAP net income (loss) from continuing
operations per share, basic

$

(0.07)

$

(0.19)

$

(0.06)

$

(0.20)

$

(0.36)

GAAP net income (loss) from discontinued
operations per share, basic

$

—

$

—

$

—

$

—

$

(0.01)

Adjustment for stock-based compensation

—

—

—

—

—

Adjustment for restructuring costs

—

—

—

—

0.01

Non-GAAP net income (loss) from discontinued
operations per share, basic

$

—

$

—

$

—

$

—

$

—

Non-GAAP net income (loss) per share, basic

$

(0.07)

$

(0.19)

$

(0.06)

$

(0.20)

$

(0.36)

GAAP net income (loss) from continuing
operations per share, diluted

$

(0.12)

$

(0.24)

$

(0.05)

$

(0.29)

$

(0.55)

Adjustment for stock-based compensation

0.05

0.05

0.04

0.14

0.16

Adjustment for impairment charges

—

—

—

—

0.02

Adjustment for restructuring costs

—

—

—

—

0.01

Adjustment for significant non-recurring gain

—

—

(0.05)

(0.05)

—

Non-GAAP net income (loss) from continuing
operations per share, diluted

$

(0.07)

$

(0.19)

$

(0.06)

$

(0.20)

$

(0.36)

GAAP net income (loss) from discontinued
operations per share, diluted

$

—

$

—

$

—

$

—

$

(0.01)

Adjustment for stock-based compensation

—

—

—

—

—

Adjustment for restructuring costs

—

—

—

—

0.01

Non-GAAP net income (loss) from discontinued
operations per share, diluted

$

—

$

—

$

—

$

—

$

—

Non-GAAP net income (loss) per share, diluted

$

(0.07)

$

(0.19)

$

(0.06)

$

(0.20)

$

(0.36)

GAAP gross margin percentage from continuing
operations

37.4

%

(23.3)

%

43.9

%

39.4

%

23.5

%

Adjustment for stock-based compensation included
in cost of revenue

3.6

%

11.4

%

2.9

%

3.1

%

5.8

%

Non-GAAP gross margin percentage from
continuing operations

41.0

%

(11.9)

%

46.8

%

42.5

%

29.3

%

 

QUICKLOGIC CORPORATION

SUPPLEMENTAL DATA

(Unaudited)

Percentage of Revenue

Change in Revenue

Q3 2026

Q3 2025

Q2 2026

Q3 2026 to
Q3 2025

Q3 2026 to
Q2 2026

COMPOSITION OF REVENUE

Revenue by product: (1)

New products

79

%

47

%

85

%

324

%

(13)

%

Mature products

21

%

53

%

15

%

2

%

33

%

Revenue by geography:

Asia Pacific

9

%

47

%

8

%

(53)

%

1

%

North America

85

%

51

%

88

%

323

%

(9)

%

Europe

6

%

2

%

4

%

736

%

54

%

(1)

New products include all products manufactured on 180 nanometer or smaller semiconductor processes, and eFPGA IP and related professional services. Mature products include all products produced on semiconductor processes larger than 180 nanometer. Associated royalty revenues are included within their respective device’s classification. The Company notes it did not recognize revenue at the SensiML entity held for disposal during the periods presented herein.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/quicklogic-reports-fiscal-third-quarter-2026-financial-results-302935485.html

SOURCE QuickLogic Corporation

Continue Reading

Technology

Resideo Announces Third Quarter 2026 Financial Results and Updates 2026 Outlook

Published

on

By

Total revenue of $727 million, up 3% year-over-year, and revenue excluding OEM Security up 6% year-over-yearGross margin of 40.4%, marking the 14th consecutive quarter of year-over-year gross margin expansionGAAP income from continuing operations, net of taxes, of $31 million, down 66% compared to $90 million in third quarter of 2025; Standalone Adjusted EBITDA (1)of $154 million, up 5% year-over-yearGAAP diluted EPS from continuing operations of $0.14, down 71% year-over-year; Standalone Adjusted diluted EPS (1)of $0.52, up 8% year-over-yearRepaid $1.1 billion of gross debt; total gross debt of $2.1 billion at end of third quarter

SCOTTSDALE, Ariz., Nov. 10, 2026 /PRNewswire/ — Resideo Technologies, Inc. (NYSE: REZI), a leading global developer and manufacturer of critical control and sensing solutions for residential markets, today announced financial results for the third fiscal quarter ended October 3, 2026.

Management Remarks

“Resideo delivered top and bottom line third quarter results that were near the high end of our outlook ranges in our first quarter following the separation of ADI, underscoring our team’s continued strong execution. We achieved 3% revenue growth year-over-year across all sales channels and 6% growth year-over-year excluding OEM Security, driven by customer demand for our differentiated, non-discretionary products. We also reduced our debt by $1.1 billion, using the $900 million dividend received from ADI and $200 million of cash on hand,” said Tom Surran, Resideo’s President and CEO.

“We remain focused on creating value for our customers with our differentiated products and services. That includes new AI-powered capabilities on our next-generation FORTIQ software platform, which delivers actionable intelligence that enhances customer productivity and optimizes the end-user’s experience. We are executing on our strategic priorities with discipline and consistency, creating positive momentum in a soft housing market and a dynamic macro environment.”

Third Quarter 2026 Financial Highlights

Total revenue of $727 million was up 3% compared to $703 million in the third quarter of 2025, and includes an unfavorable impact of approximately 50 basis points from foreign currency exchange. Total revenue was near the high-end of the provided outlook range for the third quarter of 2026.

Revenue excluding OEM Security of $694 million, was up 6% compared to $653 million in the third quarter of 2025, and grew year-over-year across all of our sales channels and product categories due to volume, driven by customer demand for our products, and pricing. OEM Security revenue of $33 million was down 34% compared to $50 million in the third quarter of 2025, and declined as expected due to reduced volumes from a large OEM Security customer.

Gross margin of 40.4%, marking the 14th consecutive quarter of year-over-year gross margin expansion. Gains from price increases, operational efficiencies, and tariff refunds were partially offset by unfavorable product sales mix and inflationary input costs.

Research and development expenses increased $4 million from the third quarter of 2025 driven by investments in new product launches to drive future growth. Selling, general and administrative expenses increased $24 million from the third quarter of 2025, driven primarily by $30 million of non-recurring business separation expenses associated with the ADI Spin-Off. Restructuring, impairment and extinguishment expenses increased $17 million from the third quarter of 2025 due to continued manufacturing operations optimization and higher debt extinguishment charges.

GAAP income from continuing operations, net of taxes, of $31 million was down 66% compared to $90 million in the third quarter 2025. Standalone Adjusted EBITDA(1) of $154 million was up 5% compared to $146 million in the third quarter of 2025, primarily due to higher gross profit dollars and controlled growth in operating expenses. Standalone Adjusted EBITDA was near the high-end of the provided outlook range for the third quarter of 2026.

Cash Flow and Liquidity

Net cash provided by operating activities of continuing operations was $33 million in the third quarter 2026 compared to net cash used by operating activities of continuing operations of $1.59 billion in the third quarter of 2025. The increase in cash provided by operations was primarily due to the $1.59 billion payment made in the third quarter of 2025 to Honeywell to terminate the Indemnification Agreement.

In connection with the ADI Spin-Off, Resideo received a $900 million cash dividend from ADI as partial consideration for the assets transferred in the ADI Spin-Off. We used this dividend, along with $200 million of cash on hand to repay $1.1 billion of gross debt during the third quarter. We also made a $20 million payment to ADI as part of the post-separation adjustment mechanism to true up cash. At October 3, 2026, Resideo had cash and cash equivalents of $229 million and total outstanding gross debt of $2.1 billion.

In connection with the completion of the ADI Spin-Off, Resideo’s outstanding Series A Cumulative Convertible Participating Preferred Stock (“Preferred Stock”) was reduced by 150,000 shares, leaving 350,000 shares outstanding, with a proportional adjustment to the conversion price and an ongoing smaller quarterly dividend payable on Resideo’s Preferred Stock.

ADI Spin-Off and Discontinued Operations

On August 3, 2026, Resideo completed the separation of its former ADI Global Distribution segment by distributing to Resideo common shareholders on a pro rata basis all of the issued and outstanding common stock of ADI Global Distribution Inc., the entity incorporated to hold the ADI business (the “ADI Spin-Off”). As a result of the ADI Spin-Off, we present the historical results of the ADI business as discontinued operations in our financial statements.    

Outlook

The following table summarizes Resideo’s fourth quarter 2026 and updated full year 2026 outlook:

($ in millions, except per share data)

Q4 2026

2026

Revenue

$710 – $730

$2,927 – $2,947 

Standalone Adjusted EBITDA (1)

$145 – $155

$614 – $624

Standalone Adjusted Earnings Per Share (1)

$0.42 – $0.48 

$1.92 – $1.98

Full Year Cash Provided by Operating Activities

At least $165

Conference Call and Webcast Details

Resideo will hold a conference call with investors on November 10, 2026, at 5:00 p.m. ET. The webcast can be accessed at https://investor.resideo.com, where the webcast link and related materials will be posted before the call. A replay of the webcast will be available following the presentation.

About Resideo

Resideo is a global building technologies company that is a leading developer and manufacturer of critical control and sensing solutions for residential markets. The company serves professional installers and integrators across diverse product categories, such as heating, ventilation, and air conditioning controls, combustion, life safety, security, and water. Its comfort and protection solutions can be found in more than 150 million residential and commercial spaces globally, with tens of millions of new devices sold annually. More information about Resideo and its trusted brands, including BRK, First Alert, and Honeywell Home, is available at resideo.com.

(1)

This press release includes certain Non-GAAP financial measures, including Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and other supplemental financial measures we denote as “Standalone” measures, including Standalone Adjusted EBITDA, Standalone Adjusted Net Income and Standalone Adjusted Diluted EPS, which are presented as if the ADI Spin-Off had occurred and Resideo was operating as a separate, independent company for all periods presented. See the section herein titled “Use of Non-GAAP and Standalone Supplemental Financial Measures” for more information.

Contacts:

Investors:

Media:

Christopher T. Lee

Kevin Hunt

Global Head of Strategic Finance

Director, Corporate Communications

investorrelations@resideo.com 

kevin.hunt@resideo.com 

Forward-Looking Statements

This press release and the related conference call contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements, including statements regarding our fourth quarter 2026 and full year 2026 outlook, our capital allocation and deleveraging plans, the expected benefits of the ADI Spin-Off, operational efficiency improvement, and the development, launch and adoption of new products and capabilities. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks and uncertainties, which may cause the actual results or performance of Resideo Technologies, Inc. (“Resideo” or the “Company”) to differ materially from such forward-looking statements.

Such risks and uncertainties include, but are not limited to, our ability to achieve our outlook regarding the fourth quarter 2026 and full year 2026; the ability of Resideo to drive increased customer value and financial returns and enhance strategic and operational capabilities, including through our product offerings, services, ability to compete, and manage any expected OEM Security impacts; risks and uncertainties relating to tariffs that have been or may be imposed by the United States and other governments including the timing, amount and recoverability of tariff refunds or claims in relation to refunds; risks related to our ability to achieve some or all of the expected benefits of the ADI Spin-Off, our dependence on transition services, the commercial product purchase agreement and other arrangements with ADI, our dependence on a select group of large customers, and changes to our capital structure, leverage and liquidity resulting from the ADI Spin-Off; our ability to repay outstanding debt obligations on the timing we anticipate or at all; macroeconomic conditions, including housing market fluctuations, interest rates, inflation, repair and remodeling and construction activity, costs of raw materials and components, and fuel and shipping costs; our ability to implement pricing actions; seasonal fluctuations and weather conditions affecting demand for our products; ability to successfully execute restructuring and productivity initiatives; and the other risks described under the headings “Risk Factors” and “Cautionary Statement Concerning Forward-Looking Statements” in our Annual Report on Form 10-K for the year ended December 31, 2025, our subsequent Quarterly Reports on Form 10-Q, and other periodic filings we make from time to time with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results, developments, and business decisions may differ from those envisaged by our forward-looking statements.  

Except as required by law, we undertake no obligation to update such statements to reflect events or circumstances arising after the date of this press release and we caution investors not to place undue reliance on any such forward-looking statements.

Use of Non-GAAP and Standalone Supplemental Financial Measures

This press release includes certain “Non-GAAP financial measures” as defined under the Securities Exchange Act of 1934 and in accordance with regulations issued thereunder, including Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS, as well as other supplemental financial measures we denote as “Standalone” measures, including Standalone Adjusted EBITDA, Standalone Adjusted Net Income and Standalone Adjusted Diluted EPS, which are presented as if the ADI Spin-Off had occurred and Resideo was operating as a separate, independent company for all periods presented. Management believes the use of such Non-GAAP and supplemental financial measures assists investors and our management in understanding the ongoing operating performance of the Company by presenting financial results between periods on a more comparable basis. Such Non-GAAP and supplemental financial measures should not be construed as an alternative to reported results determined in accordance with U.S. GAAP. Readers should also consider the limitations associated with these Non-GAAP and supplemental financial measures, including the potential lack of comparability of these measures from one company to another.

We have included reconciliations of these Non-GAAP and supplemental financial measures to the most directly comparable financial measures calculated and provided in accordance with U.S. GAAP at the end of this release. A reconciliation of the Non-GAAP and supplemental financial measures included as part of the outlook provided herein is not included in this release due to the number of variables in the projected range as part of such outlook and because we are currently unable to quantify accurately without unreasonable efforts certain amounts that would be required to be included in the U.S. GAAP measure or the individual adjustments for such reconciliation, including the timing and amount of restructuring, impairment and extinguishment costs, business separation costs, litigation settlements, and other non-recurring items and the related tax effects. In addition, we believe such reconciliation would imply a degree of precision that would be confusing or misleading to investors. Amounts presented in this press release may not sum due to rounding. 

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(in millions, except par value)

October 3, 2026

December 31, 2025

ASSETS

Current assets:

Cash and cash equivalents

$                 229

$                 537

Accounts receivable, net

507

414

Inventory

393

318

Other current assets

110

116

Current assets of discontinued operations

—

1,973

Total current assets

1,239

3,358

Property, plant and equipment, net

336

340

Goodwill

2,026

2,036

Intangible assets, net

341

347

Other assets

198

257

Non-current assets of discontinued operations

—

2,095

Total assets

$              4,140

$              8,433

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$                 491

$                 414

Accrued liabilities

379

430

Current liabilities of discontinued operations

—

911

Total current liabilities

870

1,755

Long-term debt

2,074

3,167

Non-current obligations payable under the Honeywell Tax Matters Agreement

—

88

Other long-term liabilities

249

257

Non-current liabilities of discontinued operations

—

249

Total liabilities

3,193

5,516

Stockholders’ equity:

Preferred stock, $0.001 par value: 100 shares authorized, 0.35 shares issued and

outstanding, and $350 liquidation preference at October 3, 2026 and 0.5 shares
issued and outstanding, and $500 liquidation preference at  December 31, 2025

337

482

Common stock, $0.001 par value: 700 shares authorized, 161 and 152 shares issued
and outstanding at October 3, 2026, respectively, and 158 and 150 shares issued and
outstanding at December 31, 2025, respectively 

—

—

Additional paid-in capital

2,352

2,391

Retained (deficit) earnings

(1,413)

345

Accumulated other comprehensive loss

(146)

(157)

Treasury stock at cost

(183)

(144)

Total stockholders’ equity

947

2,917

Total liabilities and stockholders’ equity

$              4,140

$              8,433

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

Three Months Ended

Nine Months Ended

(in millions, except per share data)

October 3,
2026

September 27,
2025

October 3,
2026

September 27,
2025

Revenue

$         727

$         703

$       2,217

$       2,108

Cost of goods sold

433

419

1,325

1,270

Gross profit

294

284

892

838

Operating expenses:

Research and development expenses

37

33

110

91

Selling, general and administrative expenses

159

135

445

403

Intangible asset amortization

6

7

19

21

Restructuring, impairment and extinguishment costs

20

3

43

4

Total operating expenses

222

178

617

519

Operating income

72

106

275

319

Indemnification Agreement expense (1)

—

—

—

972

Other expense (income), net (2)

3

6

(80)

23

Interest expense, net

31

30

97

81

Income (loss) from continuing operations before taxes

38

70

258

(757)

Provision (benefit) for income taxes

7

(20)

88

(22)

Income (loss) from continuing operations, net of taxes

31

90

170

(735)

Income (loss) from discontinued operations, net of taxes

(9)

66

(13)

72

Net income (loss)

22

156

157

(663)

Less: preferred stock dividends

7

9

24

26

Less: undistributed income allocated to preferred stockholders

2

16

15

—

Net income (loss) available to common stockholders

$          13

$         131

$         118

$        (689)

Income (loss) from continuing operations, net of taxes, available to common
stockholders

$          22

$          75

$         135

$        (753)

Income (loss) from discontinued operations, net of taxes, available to common
stockholders

(9)

56

(17)

64

Net income (loss) available to common stockholders

$          13

$         131

$         118

$        (689)

Income (loss) from continuing operations, net of taxes

$          31

$          90

$         170

$        (735)

Less: preferred stock dividends

6

6

18

18

Less: undistributed income allocated to preferred stockholders

3

9

17

—

Income (loss) from continuing operations, net of taxes, available to common
stockholders

$          22

$          75

$         135

$        (753)

Income (loss) from discontinued operations, net of taxes

$           (9)

$          66

$         (13)

$           72

Less: preferred stock dividends

1

3

6

8

Less: undistributed (loss) income allocated to preferred stockholders

(1)

7

(2)

—

Income (loss) from discontinued operations, net of taxes, available to common
stockholders

$           (9)

$           56

$         (17)

$           64

Net income (loss) available to common stockholders

$          13

$         131

$         118

$        (689)

Earnings (loss) per common share:

Basic earnings (loss) per share from continuing operations

$        0.14

$        0.50

$        0.89

$       (5.05)

Basic earnings (loss) per share from discontinued operations

(0.06)

0.38

(0.11)

0.43

Basic earnings (loss) per share attributable to common shareholders

$        0.08

$        0.88

$        0.78

$       (4.62)

Diluted earnings (loss) per share from continuing operations

$        0.14

$        0.49

$        0.88

$       (5.05)

Diluted earnings (loss) per share from discontinued operations

(0.06)

0.36

(0.11)

0.43

Diluted earnings (loss) per share attributable to common shareholders

$        0.08

$        0.85

$        0.77

$       (4.62)

Weighted average common shares outstanding:

Basic

152

149

151

149

Diluted

154

154

154

149

(1)

Represents the expense incurred pursuant to the Indemnification Agreement, which, prior to its termination, we paid our regularly scheduled payments of $70 million during 2025.

(2)

For the nine months ended October 3, 2026, Other expense (income), net, primarily represents the $77 million gain recognized pursuant to the termination of the Honeywell Tax Matters Agreement.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 

(UNAUDITED)

Three Months Ended

Nine Months Ended

(in millions)

October 3,
2026

September 27,
2025

October 3,
2026

September 27,
2025

Cash Flows From Operating Activities:

Net income (loss)

$          22

$         156

$         157

$        (663)

Income (loss) from discontinued operations, net of taxes

(9)

66

(13)

72

Income (loss) from continuing operations, net of taxes

31

90

170

(735)

Adjustments to reconcile net income (loss) from continuing operations to net
cash from operating activities:

Depreciation and amortization

21

21

64

60

Restructuring, impairment and extinguishment costs

20

3

43

4

Stock-based compensation expense

10

10

30

30

Deferred income taxes

—

—

44

(26)

Other, net

1

(11)

—

(2)

Changes in assets and liabilities:

Accounts receivable, net

(48)

(18)

(102)

(9)

Inventory

(59)

(7)

(80)

(9)

Other current assets

(3)

1

5

(14)

Accounts payable

71

(1)

75

(30)

Accrued liabilities

(4)

(99)

(53)

(9)

Non-current obligations payable under the Honeywell Tax Matters Agreement

—

—

(88)

—

Non-current obligations payable under the Indemnification Agreement

—

(1,625)

—

(723)

Other non-current, net

(7)

47

3

7

Net cash provided by (used in) continuing operations operating activities

33

(1,589)

111

(1,456)

Net cash (used in) provided by discontinued operations operating activities

(32)

18

(107)

20

Net cash provided by (used in) operating activities

1

(1,571)

4

(1,436)

Cash Flows From Investing Activities:

Capital expenditures

(22)

(13)

(62)

(43)

Other investing activities, net

—

—

10

—

Net cash used in continuing operations investing activities

(22)

(13)

(52)

(43)

Net cash used in discontinued operations investing activities

(5)

(15)

(30)

(36)

Net cash used in investing activities

(27)

(28)

(82)

(79)

Cash Flows From Financing Activities:

Proceeds from issuance of long-term debt

—

1,198

—

1,198

Repayments of long-term debt

(1,100)

—

(1,109)

(3)

Payments of debt facility issuance and modification costs

—

(1)

—

(23)

Acquisition of treasury stock to cover stock award tax withholding

(6)

(7)

(39)

—

Preferred stock dividend payments

(8)

(6)

(20)

(18)

Cash dividend received from ADI in connection with the ADI Spin-Off

900

—

900

—

Cash paid to ADI in connection with the ADI Spin-Off

(20)

—

(20)

—

Other financing activities, net

1

11

3

13

Net cash (used in) provided by continuing operations financing activities

(233)

1,195

(285)

1,167

Net cash used in discontinued operations financing activities

(454)

(3)

(60)

(8)

Net cash (used in) provided by financing activities

(687)

1,192

(345)

1,159

Effect of foreign exchange rate changes on cash, cash equivalents and restricted
cash

(6)

(1)

(9)

9

Net decrease in cash, cash equivalents and restricted cash

(719)

(408)

(432)

(347)

Cash, cash equivalents and restricted cash at beginning of period

949

754

662

693

Less: cash, cash equivalents and restricted cash of discontinued operations

—

93

—

93

Cash, cash equivalents and restricted cash of continuing operations at end of
period

$         230

$         253

$         230

$         253

 

NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS

ADJUSTED NET INCOME AND ADJUSTED DILUTED EARNINGS PER SHARE

(UNAUDITED)

Three Months Ended

Nine Months Ended

(in millions, except per share data)

October 3,
2026

September 27,
2025

October 3,
2026

September 27,
2025

GAAP Net income (loss) from continuing operations

$           31

$           90

$          170

$         (735)

Less: preferred stock dividends

6

6

18

18

Less: undistributed income allocated to preferred stockholders

3

9

17

—

GAAP Net income (loss) from continuing operations  available to
common stockholders

$           22

$           75

$          135

$         (753)

Indemnification Agreement expense (1)

—

—

—

972

One-time tax impact of Indemnification Agreement

—

(34)

—

(78)

Termination of the Honeywell Tax Matters Agreement (2)

—

—

(33)

—

Intangible asset amortization

6

7

19

21

Business separation costs

30

—

30

—

Restructuring, impairment and extinguishment costs

20

3

43

4

Stock-based compensation expense

10

10

30

30

Litigation settlement

—

—

18

—

Undistributed income allocated to preferred stockholders

3

9

17

—

Other (3)

4

6

(1)

24

Tax effect of applicable non-GAAP adjustments (4)

(15)

(7)

(32)

(20)

Adjusted Net income

$           80

$           69

$          226

$          200

Non-recurring standalone adjustments, net of taxes (5)

—

5

5

14

Standalone Adjusted Net Income From Continuing Operations

$           80

$           74

$          231

$          214

Three Months Ended

Nine Months Ended

October 3,
2026

September 27,
2025

October 3,
2026

September 27,
2025

Net income (loss) from continuing operations available to common
shareholders per diluted common share

$         0.14

$         0.49

$         0.88

$        (4.99)

Indemnification Agreement expense (1)

—

—

—

6.44

One-time tax impact of Indemnification Agreement

—

(0.22)

—

(0.52)

Termination of the Honeywell Tax Matters Agreement (2)

—

—

(0.21)

—

Intangible asset amortization

0.04

0.05

0.12

0.14

Business separation costs

0.19

—

0.19

—

Restructuring, impairment and extinguishment costs

0.13

0.02

0.28

0.03

Stock-based compensation expense

0.06

0.06

0.19

0.20

Litigation settlement

—

—

0.12

—

Undistributed income allocated to preferred stockholders

0.02

0.06

0.11

—

Other (3)

0.03

0.04

(0.01)

0.16

Tax effect of applicable non-GAAP adjustments (4)

(0.09)

(0.05)

(0.21)

(0.13)

Adjusted Diluted Earnings Per Share

$         0.52

$         0.45

$         1.46

$         1.33

Non-recurring standalone adjustments, net of taxes  (5)

—

0.03

0.04

0.09

Standalone Adjusted Diluted Earnings Per Share

$         0.52

$         0.48

$         1.50

$         1.42

(1)

Refer to the Unaudited Consolidated Statements of Operations herein.

(2)

We recognized a gain of $77 million in Other income and derecognized $44 million of deferred tax assets that were no longer realizable to Income tax expense in connection with the termination of the Honeywell Tax Matters Agreement.

(3)

Other includes net periodic pension benefit costs, excluding service costs, foreign exchange transaction loss (income), gain on sale of assets and miscellaneous other non-recurring, non-operating income and loss.

(4)

We calculate the tax effect of relevant non-GAAP adjustments by applying a flat statutory tax rate of 25% for all non-deductible and taxable adjustments.

(5)

Reflects methodology differences between continuing operations basis of accounting and Standalone results (e.g., executive compensation for certain executives who transferred to ADI as part of the separation or retired from Resideo is wholly retained in continuing operations). Standalone results are intended to present historical results as if the ADI Spin-Off had occurred and Resideo was operating as a separate, independent company for all periods presented.

 

NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS

GAAP NET INCOME AND ADJUSTED EBITDA

(UNAUDITED)

Three Months Ended

Nine Months Ended

(in millions)

October 3,
2026

September 27,
2025

October 3,
2026

September 27,
2025

Revenue

$         727

$         703

$       2,217

$       2,108

GAAP Net income (loss) from continuing operations

$          31

$          90

$         170

$        (735)

GAAP Net income (loss) from continuing operations as a
% of revenue

4.3 %

12.8 %

7.7 %

(34.9) %

Provision (benefit) for income taxes 

7

(20)

88

(22)

GAAP Net income (loss) from continuing operations
before taxes

38

70

258

(757)

Indemnification Agreement expense (1)

—

—

—

972

Termination of Honeywell Tax Matters Agreement (2)

—

—

(77)

—

Interest expense, net

31

30

97

81

Depreciation and amortization

21

21

64

60

Business separation costs

30

—

30

—

Stock-based compensation expense

10

10

30

30

Restructuring, impairment and extinguishment costs

20

3

43

4

Litigation settlement

—

—

18

—

Other (3)

4

6

(1)

24

Adjusted EBITDA

$         154

$         140

$         462

$         414

Non-recurring standalone adjustments (4)

—

6

7

19

Standalone Adjusted EBITDA

$         154

$         146

$         469

$         433

Standalone Adjusted EBITDA as a % of revenue

21.2 %

20.8 %

21.2 %

20.5 %

(1)

Refer to the Unaudited Consolidated Statements of Operations herein.

(2)

We recognized a gain of $77 million in Other income and derecognized $44 million of deferred tax assets that were no longer realizable to Income tax expense in connection with the termination of the Honeywell Tax Matters Agreement.

(3)

Other includes net periodic pension benefit costs, excluding service costs, foreign exchange transaction loss (income), gain on sale of assets and miscellaneous other non-recurring, non-operating income and loss.

(4)

Reflects methodology differences between continuing operations basis of accounting and Standalone results (e.g., executive compensation for certain executives who transferred to ADI as part of the separation or retired from Resideo is wholly retained in continuing operations). Standalone results are intended to present historical results as if the ADI Spin-Off had occurred and Resideo was operating as a separate, independent company for all periods presented.

 

Unaudited Condensed Consolidated Statement of Operations

For the Three Months Ended July 4, 2026

(UNAUDITED)

For the Three Months Ended July 4, 2026

Resideo

ADI
Discontinued
Operations

Resideo
Continuing
Operations

(in millions)

Revenue

$             1,981

$             1,243

$              738

Cost of goods sold

1,386

951

435

  Gross profit

595

292

303

Operating expenses:

  Research and development expenses

48

12

36

  Selling, general and administrative expenses

332

196

136

  Intangible asset amortization

31

25

6

  Restructuring, impairment and extinguishment costs

22

5

17

  Business separation costs

31

31

—

    Total operating expenses

464

269

195

    Income from operations

131

23

108

Other expense (income), net

(81)

2

(83)

Interest expense, net

46

13

33

    Net income before taxes

166

8

158

Provision for income taxes

69

7

62

    Net income

97

1

96

Less: preferred stock dividends

8

2

6

Less: undistributed income allocated to preferred
stockholders

10

—

10

    Net income (loss) available to common stockholders

$                79

$                 (1)

$                80

 

Unaudited Condensed Consolidated Statement of Operations

For the Three Months Ended April 4, 2026

(UNAUDITED)

For the Three Months Ended April 4, 2026

Resideo

ADI
Discontinued
Operations

Resideo
Continuing
Operations

(in millions)

Revenue

$             1,912

$             1,160

$              752

Cost of goods sold

1,361

904

457

  Gross profit

551

256

295

Operating expenses:

  Research and development expenses

48

11

37

  Selling, general and administrative expenses

340

190

150

  Intangible asset amortization

31

24

7

  Restructuring, impairment and extinguishment costs

6

—

6

  Business separation costs

24

24

—

    Total operating expenses

449

249

200

    Income from operations

102

7

95

Interest expense, net

47

14

33

    Net income (loss) before taxes

55

(7)

62

Provision (benefit) for income taxes

17

(2)

19

    Net income (loss)

38

(5)

43

Less: preferred stock dividends

9

3

6

Less: undistributed income allocated to preferred
stockholders

3

(1)

4

    Net income (loss) available to common stockholders

$                26

$                 (7)

$                33

 

Unaudited Condensed Consolidated Statement of Operations

For the Three Months Ended December 31, 2025

(UNAUDITED)

For the Three Months Ended December 31, 2025

Resideo

ADI
Discontinued
Operations

Resideo
Continuing
Operations

(in millions)

Revenue

$             1,895

$             1,145

$              750

Cost of goods sold

1,335

877

458

Gross profit

560

268

292

Operating expenses:

  Research and development expenses

47

10

37

  Selling, general and administrative expenses

321

183

138

  Intangible asset amortization

31

25

6

  Restructuring, impairment and extinguishment costs

7

3

4

  Business separation costs

14

14

—

    Total operating expenses

420

235

185

    Income from operations

140

33

107

Other income, net

(65)

(2)

(63)

Interest expense, net

49

16

33

    Net income before taxes

156

19

137

Provision (benefit) for income taxes

20

(22)

42

    Net income

136

41

95

Less: preferred stock dividends

9

3

6

Less: undistributed income allocated to preferred
stockholders

14

4

10

    Net income available to common stockholders

$               113

$                34

$                79

 

Unaudited Condensed Consolidated Statement of Operations

For the Three Months Ended September 27, 2025

(UNAUDITED)

For the Three Months Ended September 27, 2025

Resideo

ADI
Discontinued
Operations

Resideo
Continuing
Operations

(in millions)

Revenue

$             1,864

$             1,161

$              703

Cost of goods sold

1,308

889

419

Gross profit

556

272

284

Operating expenses:

  Research and development expenses

44

11

33

  Selling, general and administrative expenses

320

185

135

  Intangible asset amortization

31

24

7

  Restructuring, impairment and extinguishment costs

3

—

3

  Business separation costs

4

4

—

    Total operating expenses

402

224

178

    Income from operations

154

48

106

Other expense, net

7

1

6

Interest expense, net

37

7

30

    Net income before taxes

110

40

70

Provision (benefit) for income taxes

(46)

(26)

(20)

    Net income

156

66

90

Less: preferred stock dividends

9

3

6

Less: undistributed income allocated to preferred
stockholders

16

7

9

    Net income available to common stockholders

$               131

$                56

$                75

 

Unaudited Condensed Consolidated Statement of Operations

For the Three Months Ended June 28, 2025

(UNAUDITED)

For the Three Months Ended June 28, 2025

Resideo

ADI
Discontinued
Operations

Resideo
Continuing
Operations

(in millions)

Revenue

$             1,943

$             1,233

$              710

Cost of goods sold

1,374

949

425

Gross profit

569

284

285

Operating expenses:

  Research and development expenses

41

9

32

  Selling, general and administrative expenses

319

183

136

  Intangible asset amortization

30

23

7

  Restructuring, impairment and extinguishment costs

2

1

1

    Total operating expenses

392

216

176

    Income from operations

177

68

109

Indemnification Agreement expense

882

—

882

Other expense (income), net

9

(2)

11

Interest expense, net

24

(1)

25

    Net income (loss) before taxes

(738)

71

(809)

Provision for income taxes

87

83

4

    Net loss

(825)

(12)

(813)

Less: preferred stock dividends

8

2

6

    Net loss available to common stockholders

$              (833)

$               (14)

$             (819)

 

Unaudited Condensed Consolidated Statement of Operations

For the Three Months Ended March 29, 2025

(UNAUDITED)

For the Three Months Ended March 29, 2025

Resideo

ADI
Discontinued
Operations

Resideo
Continuing
Operations

(in millions)

Revenue

$             1,770

$             1,075

$              695

Cost of goods sold

1,259

833

426

Gross profit

511

242

269

Operating expenses:

  Research and development expenses

35

9

26

  Selling, general and administrative expenses

306

174

132

  Intangible asset amortization

30

23

7

  Restructuring, impairment and extinguishment costs

4

4

—

    Total operating expenses

375

210

165

    Income from operations

136

32

104

Indemnification Agreement expense

90

—

90

Other expense, net

6

—

6

Interest expense, net

25

(1)

26

    Net income (loss) before taxes

15

33

(18)

Provision (benefit) for income taxes

9

15

(6)

    Net income (loss)

6

18

(12)

Less: preferred stock dividends

9

3

6

    Net income (loss) available to common stockholders

$                 (3)

$                15

$               (18)

 

NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS

ADJUSTED EBITDA

(UNAUDITED)

For the Three Months Ended

(in millions)

March 29, 2025

June 28, 2025

September 27, 2025

December 31, 2025

April 4, 2026

July 4, 2026

October 3, 2026

Net Income (loss) from continuing operations

$             (12)

$         (813)

$                   90

$                  95

$           43

$         96

$              31

Provision (benefit) for income taxes

(6)

4

(20)

42

19

62

7

Interest expense, net

26

25

30

33

33

33

31

Depreciation and amortization

19

20

21

20

22

21

21

Stock-based compensation expense

11

9

10

10

10

10

10

Restructuring, impairment and extinguishment costs

—

1

3

4

6

17

20

Business separation costs

—

—

—

—

—

—

30

Litigation Settlement

—

—

—

—

18

—

—

Indemnification Agreement expense

90

882

—

—

—

—

—

Termination of Honeywell Tax Matters Agreement

—

—

—

—

—

(77)

—

Gain on sale of business

—

—

—

(52)

—

—

—

Other (1)

6

12

6

(10)

1

(6)

4

Adjusted EBITDA

$             134

$          140

$                 140

$                 142

$         152

$        156

$             154

Non-recurring standalone adjustments (2)

5

8

6

6

6

1

—

Standalone Adjusted EBITDA

$             139

$          148

$                 146

$                 148

$         158

$        157

$             154

(1)

Other includes net periodic pension benefit costs, excluding service costs, foreign exchange transaction loss (income), gain on sale of assets and miscellaneous other non-recurring, non-operating income and loss.

(2)

Reflects methodology differences between continuing operations basis of accounting and Standalone results (e.g., executive compensation for certain executives who transferred to ADI as part of the separation or retired from Resideo is wholly retained in continuing operations). Standalone results are intended to present historical results as if the ADI Spin-Off had occurred and Resideo was operating as a separate, independent company for all periods presented.

 

NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS

ADJUSTED NET INCOME AND ADJUSTED DILUTED EARNINGS PER SHARE

(UNAUDITED)

For the Three Months Ended

(in millions)

March 29, 2025

June 28, 2025

September 27, 2025

December 31, 2025

April 4, 2026

July 4, 2026

October 3, 2026

Net income (loss) from continuing operations available to
common stockholders

$             (18)

$          (819)

$                   75

$                   79

$           33

$          80

$               22

Intangible asset amortization

7

7

7

6

7

6

6

Stock-based compensation expense

11

9

10

10

10

10

10

Restructuring, impairment and extinguishment costs

—

1

3

4

6

17

20

Business separation costs

—

—

—

—

—

—

30

Litigation Settlement

—

—

—

—

18

—

—

Indemnification Agreement expense

90

882

—

—

—

—

—

Tax impact of terminating the IRA

—

(44)

(34)

6

—

—

—

Termination of Honeywell Tax Matters Agreement

—

—

—

—

—

(77)

—

Tax impact of terminating the Honeywell Tax Matters Agreement

—

—

—

—

—

44

—

Gain on sale of business

—

—

—

(52)

—

—

—

Tax impact of sale of business

—

—

—

14

—

—

—

Undistributed income allocated to preferred stockholders

—

—

9

10

4

10

3

Other (1)

6

12

6

(10)

1

(6)

4

Tax effect of applicable non-GAAP adjustments

(6)

(7)

(7)

(3)

(11)

(7)

(15)

Adjusted Net Income

$               90

$            41

$                   69

$                   64

$           68

$          77

$               80

Non-recurring standalone adjustments, net of taxes (2)

4

6

5

5

5

1

—

Standalone Adjusted Net Income

$               94

$            47

$                   74

$                   69

$           73

$          78

$               80

Diluted shares (in millions)

148

151

154

155

155

154

154

Standalone Adjusted Diluted Earnings Per Share

$             0.64

$          0.31

$                  0.48

$                 0.45

$         0.47

$        0.51

$             0.52

(1)

Other includes net periodic benefit costs, excluding service costs, foreign exchange transaction loss (income), gain on sale of assets and miscellaneous other non-recurring, non-operating income and loss.

(2) 

Reflects methodology differences between continuing operations basis of accounting and Standalone results (e.g., executive compensation for certain executives who transferred to ADI as part of the separation or retired from Resideo is wholly retained in continuing operations). Standalone results are intended to present historical results as if the ADI Spin-Off had occurred and Resideo was operating as a separate, independent company for all periods presented.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/resideo-announces-third-quarter-2026-financial-results-and-updates-2026-outlook-302935565.html

SOURCE Resideo Technologies, Inc.

Continue Reading

Trending